Daniel B. Bellissimo

2.9k citations

57 papers · 2.3k · 1 hit paper · h-index 21

Impact in

Hematology top 1%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
Genetics top 5%
- Genomics and Rare Diseases
- Blood disorders and treatments

Papers in

Hematology 40
- Platelet Disorders and Treatments 28
- Blood groups and transfusion 21
Genetics 11
- Blood disorders and treatments 8
- Genomic variations and chromosomal abnormalities 5
- Genomics and Rare Diseases 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Hemoglobinopathies and Related Disorders 4

Co-authors: C. Sue Richards (2 shared papers)Wayne W. Grody (2 shared papers)Madhuri Hegde (2 shared papers)Brian E. Ward (1 shared paper)Elaine Lyon (1 shared paper)Sherri J. Bale (1 shared paper)Soma Das (1 shared paper)Robert R. Montgomery (18 shared papers)
Journals: Blood (19 papers)Transfusion (5 papers)Journal of Thrombosis and Haemostasis (3 papers)Archives of Biochemistry and Biophysics (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Daniel B. Bellissimo

56 papers receiving 2.3k citations

Daniel B. Bellissimo's Hit Papers

align trajectories log scale

ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 2008 · 689 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2008 Genetics in Medicine

Peers

Countries citing papers authored by Daniel B. Bellissimo

Since Specialization

Citations

This map shows the geographic impact of Daniel B. Bellissimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Bellissimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Bellissimo more than expected).

Fields of papers citing papers by Daniel B. Bellissimo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel B. Bellissimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Bellissimo. The network helps show where Daniel B. Bellissimo may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel B. Bellissimo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel B. Bellissimo Line = papers co-authored together Daniel B. Bellissimo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 Genetics in Medicine ·C. Sue Richards, Sherri J. Bale, Daniel B. Bellissimo, Soma Das, Wayne W. Grody, Madhuri Hegde, Elaine Lyon, Brian E. Ward Hit paper breakdown →	2008	689
2	Sequence and nitrate regulation of the Arabidopsis thaliana mRNA encoding nitrate reductase, a metalloflavoprotein with three functional domains. Proceedings of the National Academy of Sciences ·Nigel M. Crawford, Martin A. Smith, Daniel B. Bellissimo, Ronald W. Davis	1988	176
3	Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival Blood ·Sandra L. Haberichter, Michael Balistreri, Pamela A. Christopherson, Patricia A. Morateck, Stefana Gavazova, Daniel B. Bellissimo, Marilyn J. Manco‐Johnson, Joan Cox Gill	2006	162
4	A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders Blood ·Ilenia Simeoni, Jonathan C. Stephens, Fengyuan Hu, Sri V. V. Deevi, Karyn Mégy, Tadbir K. Bariana, Claire Lentaigne, Sol Schulman	2016	155
5	Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele‐specific primers Transfusion ·Bjørn R. Skogen, Daniel B. Bellissimo, Martin J. Hessner, S Santoso, Richard H. Aster, PJ Newman, JG McFarland	1994	126
6	Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States Blood ·Veronica Heather Flood, Pamela A. Christopherson, Joan Cox Gill, Kenneth Dale Friedman, Sandra L. Haberichter, Daniel B. Bellissimo, Rupa Udani, Mahua Dasgupta	2016	104
7	VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population Blood ·Daniel B. Bellissimo, Pamela A. Christopherson, Veronica Heather Flood, Joan Cox Gill, Kenneth Dale Friedman, Sandra L. Haberichter, Amy D. Shapiro, Thomas C. Abshire	2011	91
8	Crucial role for the VWF A1 domain in binding to type IV collagen Blood ·Veronica Heather Flood, Abraham C. Schlauderaff, Sandra L. Haberichter, Tricia L. Slobodianuk, Paula M. Jacobi, Daniel B. Bellissimo, Pamela A. Christopherson, Kenneth Dale Friedman	2015	78
9	Curated disease‐causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH Journal of Thrombosis and Haemostasis ·Karyn Mégy, Kate Downes, Ilenia Simeoni, Loredana Bury, Joannella Morales, Rutendo P. Mapeta, Daniel B. Bellissimo, Paul F. Bray	2019	76
10	Importance of complete phenotyping in prenatal whole exome sequencing Human Genetics ·Mahmoud Aarabi, Olivia Sniezek Carney, Huaiyang Jiang, Devereux N. Saller, Daniel B. Bellissimo, Svetlana A. Yatsenko, Aleksandar Rajkovic	2018	64
11	Behavioral, biochemical, and genetic analysis of iron metabolism in high‐intensity blood donors Transfusion ·Alan E. Mast, Tisha M. Foster, Holly L. Pinder, Craig A. Beczkiewicz, Daniel B. Bellissimo, Anthony Bruce Murphy, Steve Kovacevic, Victor J. Wroblewski	2008	61
12	High‐throughput red blood cell antigen genotyping using a nanofluidic real‐time polymerase chain reaction platform Transfusion ·Kathleen A. Hopp, Kathleen M. Weber, Daniel B. Bellissimo, Susan T. Johnson, Bradley C. Pietz	2009	56
13	Critical von Willebrand factor A1 domain residues influence type VI collagen binding Journal of Thrombosis and Haemostasis ·Veronica Heather Flood, Joan C. Gill, Pamela A. Christopherson, Daniel B. Bellissimo, Kenneth Dale Friedman, Sandra L. Haberichter, Steven R. Lentz, Robert R. Montgomery	2012	53
14	Molecular cloning of human liver sulfite oxidase Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Robert M. Garrett, Daniel B. Bellissimo, K.V. Rajagopalan	1995	42
15	Technical standards and guidelines: Venous thromboembolism (Factor V Leiden and prothrombin 20210G>A testing): A disease-specific supplement to the standards and guidelines for clinical genetics laboratories Genetics in Medicine ·Elaine Spector, Wayne W. Grody, Carla J. Matteson, Glenn E. Palomaki, Daniel B. Bellissimo, Daynna J. Wolff, Linda Arthur Bradley, Thomas W. Prior	2005	39
16	L-Tryptophan injection fails to alter nutrient selection by rats Physiology & Behavior ·John C. Peters, Daniel B. Bellissimo, Alfred E. Harper	1984	36
17	αIIbβ3 variants defined by next-generation sequencing: Predicting variants likely to cause Glanzmann thrombasthenia Proceedings of the National Academy of Sciences ·Lorena Buitrago, Augusto Rendon, Yupu Liang, Ilenia Simeoni, Ana Negri, Marta Filizola, Willem Hendrik Ouwehand, Barry Coller	2015	32
18	Molecular determination of RHD zygosity:predicting risk of hemolytic disease of the fetus and newborn related to anti‐D Prenatal Diagnosis ·Kevin Pirelli, Bradley C. Pietz, Susan T. Johnson, Holly L. Pinder, Daniel B. Bellissimo	2010	28
19	Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial The Lancet Haematology ·Margaret V. Ragni, Scott D. Rothenberger, Robert Feldman, Danielle Nance, Andrew D. Leavitt, Lynn M. Malec, Roshni Kulkarni, Robert Francis Sidonio	2023	26
20	Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200 Immunohematology ·Carolyn M. Jenkins, Susan T. Johnson, Daniel B. Bellissimo, Jerome L. Gottschall	2005	21

About Daniel B. Bellissimo

Daniel B. Bellissimo is a scholar working on Hematology, Genetics, Genetics, Immunology and Pathology and Forensic Medicine, having authored 57 papers that have together received 2.3k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (28 papers), Blood groups and transfusion (21 papers), Blood disorders and treatments (8 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Genomic variations and chromosomal abnormalities (5 papers), Genomics and Rare Diseases (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (581 citations), Genetics (206 citations), Internal Medicine (41 citations) and Cardiology and Cardiovascular Medicine (194 citations). Daniel B. Bellissimo has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include C. Sue Richards, Wayne W. Grody, Madhuri Hegde, Brian E. Ward, Elaine Lyon, Sherri J. Bale, Soma Das, Robert R. Montgomery, Sandra L. Haberichter and Nigel M. Crawford. Their work appears in journals such as Blood, Transfusion, Journal of Thrombosis and Haemostasis, Archives of Biochemistry and Biophysics and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Daniel B. Bellissimo

Impact in

Papers in i

In The Last Decade

Daniel B. Bellissimo

Daniel B. Bellissimo's Hit Papers

Peers

Countries citing papers authored by Daniel B. Bellissimo

Fields of papers citing papers by Daniel B. Bellissimo

All Works

About Daniel B. Bellissimo

Explore authors with similar magnitude of impact

Papers in